Breaking News

Financial Report: Thermo Fisher Scientific

January 31, 2013

Revenues up 6% in the quarter

Thermo Fisher Scientific

4Q Revenues: $3.3 billion (+6%)

4Q Earnings: $376.4 million (+12%)

FY Revenues: $12.5 billion (+8%)

FY Earnings: $1.2 billion (+9%)

Comments: Analytical Technologies Segment revenue was up 2% to $1.1 billion in the quarter. Specialty Diagnostics Segment revenue increased 12% to $792 million. Laboratory Products and Services Segment revenue increased 4% to $1.5 billion.
blog comments powered by Disqus
  • Staying Ahead in the Small Molecule Space

    Staying Ahead in the Small Molecule Space

    Dr. Matthew Moorcroft, VP Global Marketing, Cambrex||September 8, 2016
    Understand what is happening in the market and react accordingly

  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments

  • Patent Law  and Contract Manufacturing

    Patent Law and Contract Manufacturing

    Beverly W. Lubit, Member of the Firm, Chiesa Shahinian & Giantomasi||September 8, 2016
    Analyzing the impact of The Medicines Co. vs. Hospira Inc. decision